Inhibitory effect of hexahydrocurcumin on human platelet aggregation

Nat Prod Commun. 2012 Jul;7(7):883-4.

Abstract

The effects of hexahydrocurcumin on adenosine diphosphate (ADP)-induced human platelet aggregation were studied. Treatment of human platelet-rich plasma with hexahydrocurcumin resulted in an inhibitory effect on platelet aggregation, suggesting the potential of this compound as an anti-atherosclerogenic agent in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Curcumin / analogs & derivatives*
  • Curcumin / chemistry
  • Curcumin / pharmacology
  • Humans
  • Molecular Structure
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / chemistry
  • Platelet Aggregation Inhibitors / pharmacology*

Substances

  • Platelet Aggregation Inhibitors
  • hexahydrocurcumin
  • Curcumin